OakChart

ASP Isotopes Inc

ASPIBasic Materials·Specialty Chemicals·USA·Micro·NASD·Nov 13 • 7:01 AM ET

1.92+0.05 (2.67%)
2026-11-13 13:18 CET
Market cap
$294.36M
Revenue, TTM
30.85 USD m
Net income, TTM
-132.05 USD m
Free cash flow, TTM
-83.58 USD m
EPS diluted, TTM
-1.32
-
Compare

Price

ASPI against its 20, 50 and 200-day averages
Terms2050200Earnings
Patternshover a marker to name it
RS 0Sales 4.47Price4.472.004.006.008.007.0M14.0MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ASPIclose 1.9220-day 1.9950-day 2.58200-day 4.571.9252w high 8.8852-week range, not 6 months

78.4% under the 52-week high of 8.88 on 13 Nov 2025. 52-week low 1.66 on 5 Nov 2026. Last 15 sessions, 32.5% high to low

Volume 0.07× normal · the line is the 50-bar volume average

Setup. RS line 0
CANSLIM 2 of 6 — fails: 52-Week High/Low: 0-10% below High; Performance: Year +50%; Institutional Ownership: Over 50% — not on the tape: EPS Growth This Year: High (>25%)
VCP 3 of 6 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High
Minervini 0 of 4 — fails: 200-Day Simple Moving Average: Price above SMA200; 50-Day Simple Moving Average: SMA50 above SMA200; 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 0 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5; 200-Day Simple Moving Average: Price above SMA200
Leaders 1 of 5 — fails: 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%; 52-Week High/Low: 0-10% below High
Breakout 0 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2; 50-Day Simple Moving Average: Price above SMA50; 200-Day Simple Moving Average: Price above SMA200
Growth 1 of 4 — fails: Return on Equity: Over +15% — not on the tape: EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%)
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 25
Value 1 of 4 — fails: Return on Equity: Over +15%; Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 1 of 4 — fails: Float: Under 100M; 200-Day Simple Moving Average: Price above SMA200; Performance: Year +50%
Accumulation 1 of 4 — fails: Institutional Transactions: Over +10%; 200-Day Simple Moving Average: Price above SMA200; Performance: Year Up
Relative Strength 1 of 3 — fails: Performance: Year +100%; 200-Day Simple Moving Average: Price above SMA200

Profile

ASPI
52-week range, 4% of the way up
1.668.88

ASP Isotopes, Inc. is developing a differentiated isotope enrichment platform to strengthen global supply chain access to critical materials used in nuclear medicine, next-generation semiconductors, and nuclear energy. It operates through the following segments: Nuclear Fuels, Specialist Isotopes and Related Services, and Helium and LNG. The Nuclear Fuels segment engages in the research and development of technologies and methods for producing HALEU and Lithium-6 for the advanced nuclear fuels target market, including the operations of QLE. The Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods for the separation of high-value, low-volume isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Dallas, TX.

IndexRUT
Employees271
IPONov 10, 2022
Beta3.80
ATR, 14d0.19
Rel volume0.07
Short float22.93%
Insider own10.74%
Inst own48.48%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap$294.36M
Enterprise Value314.98M
Income-132.05M
Sales30.85M
Book / share2.03
Cash / share1.69
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees271
IPONov 10, 2022

Ratios

Price / earnings-
Forward price / earnings-
Price / earnings / growth-
Price / sales9.54
Price / book0.94
Price / cash1.14
Price / free cash flow-
Value / cash profit-
Value / sales10.21
Quick Ratio3.84
Current Ratio3.86
Debt / equity1.02
Long-term debt / equity0.81
Options and shortYes / Yes

Earnings

Earnings / share-1.32
Earnings next year-
Earnings next quarter-
Earnings this year-
Earnings next year-
Earnings growth, 5 years-
Past earnings growth-148.35% -129.60%
Past sales growth- -
Earnings vs last year5.80%
Sales vs last year573.40%
Earnings vs last quarter73.38%
Sales vs last quarter327.51%
EarningsJun 03
Surprise-690.00% 720.67%

Ownership

Insiders own10.74%
Insider trades-4.87%
Institutions own48.48%
Institution trades-1.44%
Return on assets-42.84%
Return on equity-104.60%
Return on capital-27.59%
Gross Margin-0.49%
Operating margin-312.31%
Profit Margin-428.00%
20-day average-3.70%
50-day average-25.47%
200-day average-57.95%

Technical

Shares out153.31M
Shares floating136.84M
Short / float22.93%
Short ratio7.59
Short interest31.37M
52-week high8.88 -78.4%
52-week low1.66 +15.7%
Volatility10.21% 9.43%
Average range0.19
Strength index41.17
Market sensitivity3.80
Relative volume0.07
Avg Volume4.13M
Volume14,923

Performance

Perf Week-7.47%
Perf Month-13.12%
Perf Quarter-52.24%
Perf Half Y-66.90%
Perf YTD-64.11%
Perf Year-76.00%
Perf 3Y28.86%
Perf 5Y-
Perf 10Y-
Recommendation1.00
Target Price13.00
Prev Close1.87
Price1.92
Change %2.67%

Analyst ratings

latest 3 of 3
DateActionAnalystRating changeTargetImplied
Dec 04, 2025InitiatedCantor FitzgeraldOverweight$13+577.1%
Oct 04, 2024InitiatedCanaccord GenuityBuy$4.50+134.4%
Dec 05, 2023InitiatedH.C. WainwrightBuy$3.25+69.3%

Peers

Mkt cap
TickerCompanyMkt cap
STDNStandard Nuclear Inc1.78B
LEUCentrus Energy Corp2.20B
BWXTBWX Technologies Inc11.47B
LTBRLightbridge Corp164.75M
NNENano Nuclear Energy Inc611.62M
CATXPerspective Therapeutics Inc101.73M
LNTHLantheus Holdings Inc6.62B
OKLOOklo Inc4.83B
CCJCameco Corp31.62B
TLXTelix Pharmaceuticals Ltd ADR3.19B

Insider trading

latest 14 of 52
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Kiessling HeatherChief Financial OfficerOct 16 '26Sale2.1921,83047,8081,504,422Oct 21 09:45 PM
Ainscow RobertCOOOct 14 '26Sale2.1122,50047,5652,225,941Oct 16 09:57 PM
Heather KiesslingAffiliateOct 16 '26Proposed Sale2.2021,83047,975Oct 16 05:23 PM
Ainscow RobertOFFICEROct 14 '26Proposed Sale2.0722,50046,575Oct 14 09:50 PM
Ryan Robert John AndrewDirectorSep 30 '26Buy2.6815,00040,200675,222Oct 01 05:52 PM
Ryan Robert John AndrewDirectorSep 28 '26Buy2.708,00021,600660,222Sep 30 06:30 AM
Todd WiderDirectorSep 25 '26Proposed Sale2.95200,000590,000Sep 25 04:08 PM
Ainscow RobertCOOSep 08 '26Sale4.298,43836,2162,248,441Sep 10 09:45 PM
Ainscow Donald GeorgeEVP, Gen Counsel, SecretarySep 02 '26Sale3.8923,67892,107776,322Sep 04 09:33 PM
Ainscow RobertCOOSep 02 '26Sale3.9025,00097,6252,256,879Sep 04 09:32 PM
Mann Paul ElliotChairman and CEOSep 04 '26Sale4.1083,759343,4129,328,570Sep 04 09:30 PM
Mann Paul ElliotChairman and CEOSep 03 '26Sale3.9283,758328,3319,412,329Sep 04 09:30 PM
Mann Paul ElliotChairman and CEOSep 02 '26Sale3.9183,758327,4949,496,087Sep 04 09:30 PM
Mann Paul ElliotDIRECTORSep 02 '26Proposed Sale3.7883,758316,605Sep 02 09:30 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 696.31B
IWMiShares Russell 2000 Index FundAUM: 77.86B
VXFVanguard Extended Market Index ETFAUM: 30.79B
MGNRAmerican Beacon GLG Natural Resources ETFAUM: 1.24B
IWOiShares Russell 2000 Growth ETFAUM: 14.25B
VTWOVanguard Russell 2000 Index ETFAUM: 16.90B
NUKZRange Nuclear Renaissance Index ETFAUM: 589.57M
SCHASchwab U.S. Small-Cap ETFAUM: 22.44B
SRVRPacer Data & Infrastructure Real Estate ETFAUM: 286.85M
VAWVanguard Materials ETFAUM: 3.01B

News

latest 14 of 198
  • ASP Isotopes Inc. Announces that Renergen Limited's Virginia Gas Project has Achieved Stable Liquid Helium Production (GlobeNewswire)
  • Quantum Leap Energy and Necsa Sign Binding Heads of Agreement to Establish Joint Venture for HALEU Production in South Africa (GlobeNewswire) +6.76%
  • Did ASP Isotopes Inc. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire) -11.11%
  • ASP Isotopes Hosts Inaugural Capital Markets Day and Provides Operational Update (GlobeNewswire)
  • ASP Isotopes Inc. Announces that Renergen Limited's Subsidiary has Commenced Commissioning of Liquid Helium Plant in South Africa (GlobeNewswire)
  • ASP Isotopes Announces Quantum Leap Energy is Evaluating Metal Conversion Opportunities in Namibia (GlobeNewswire)
  • ENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update (Business Wire) -5.85%
  • ASP Isotopes Inc. Announces that Renergen Limited's Subsidiary has Entered into a Take-or-Pay Contract for the Supply of Liquified Natural Gas to Be Produced at the Virginia Gas Project in South Africa (GlobeNewswire)
  • ASP Isotopes to Participate in Citi's 2026 Natural Resources Conference (GlobeNewswire) -5.59%
  • ASP Isotopes Issues Letter to Shareholders (GlobeNewswire)
  • ASP Isotopes to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026 (GlobeNewswire) +12.43%
  • ASP Isotopes to Hold Capital Markets Day on September 8 (GlobeNewswire) -6.79%
  • ASP Isotopes Announces Quantum Leap Energy Research Agreement with Texas A&M Engineering Experiment Station to Advance Uranium Conversion Technology (GlobeNewswire) +9.51%
  • Join the Live Investor Webinar for Noble Africa, the Proposed ASP Isotopes Spin-Out Creating a Public Helium Company (Business Wire)

Quarterly earnings

2026Q1 EPS -0.060 matched -0.060, from -0.120 a year earlier. Sales 4.43 matched 4.43, from 1.10 a year earlier
EPS
0.0000-1.0302024Q2 EPS -0.24024Q22024Q3 EPS -0.090 against -0.09024Q32024Q4 EPS -0.130 against -0.09024Q42025Q1 EPS -0.120 against -0.12025Q12025Q2 EPS -1.030 against -1.03025Q22025Q3 EPS -0.150 against -0.15025Q32025Q4 EPS -0.790 against -0.10025Q42026Q1 EPS -0.060 against -0.06026Q1
Sales, USD millions
16.6902024Q2 sales 1.0024Q22024Q3 sales 1.10 against 1.1024Q32024Q4 sales 1.20 against 1.2024Q42025Q1 sales 1.10 against 1.0525Q12025Q2 sales 1.20 against 1.2025Q22025Q3 sales 4.90 against 4.9025Q32025Q4 sales 16.69 against 2.0325Q42026Q1 sales 4.43 against 4.4326Q1

The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.

PeriodReportedEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mSurpriseYear-ago quarterAnalystsNext session
2026Q1ended 2026-03-312026-06-03 12:00-0.060-0.060-0.1504.434.43EPS 0.0% · sales 0.0%vs 2025Q1, year-ago quarter · EPS -50.0% · sales +302.4%1 EPS · 3 salesOpen -1.80% vs SPY -0.19%. Close -9.36% vs SPY -0.70%
2025Q4ended 2025-12-312026-02-25 12:00-0.790-0.100-0.17016.692.03EPS +690.0% · sales +720.7%vs 2024Q4, year-ago quarter · EPS +507.7% · sales +1290.6%1 EPS · 3 salesOpen +1.48% vs SPY +0.41%. Close +5.90% vs SPY +0.84%
2025Q3ended 2025-09-302025-12-03 12:00-0.150-0.150-0.1454.904.90EPS 0.0% · sales -0.1%vs 2024Q3, year-ago quarter · EPS +66.7% · sales +345.0%2Open -1.25% vs SPY -0.14%. Close +2.69% vs SPY +0.35%
2025Q2ended 2025-06-302025-09-03 12:00-1.030-1.030-1.0281.201.20EPS 0.0% · sales 0.0%vs 2024Q2, year-ago quarter · EPS +329.2% · sales +20.0%1Open -0.23% vs SPY +0.37%. Close -7.15% vs SPY +0.54%
2025Q1ended 2025-03-312025-05-28 12:00-0.120-0.120-0.1221.101.05EPS 0.0% · sales +4.7%-1Open -0.50% vs SPY +0.07%. Close -2.51% vs SPY -0.58%
2024Q4ended 2024-12-312025-03-31 08:30-0.130-0.090-0.1301.201.20EPS +44.4% · sales 0.0%-1Open -4.42% vs SPY -1.05%. Close +12.07% vs SPY +0.67%
2024Q3ended 2024-09-302024-11-27 12:00-0.090-0.090-0.1181.101.10EPS 0.0% · sales 0.0%-1Open -2.74% vs SPY -0.03%. Close -14.19% vs SPY -0.30%
2024Q2ended 2024-06-302024-08-28 12:00-0.240--0.2381.00-EPS - · sales ---Open -1.96% vs SPY -0.06%. Close -9.02% vs SPY -0.58%
2026Q2ended 2026-06-30---0.170--4.47EPS - · sales -vs 2025Q2, year-ago quarter · EPS - · sales -1 EPS · 3 sales-
2026Q3ended 2026-09-30---0.150--7.34EPS - · sales -vs 2025Q3, year-ago quarter · EPS - · sales -1 EPS · 3 sales-
2026Q4ended 2026-12-31---0.090--16.63EPS - · sales -vs 2025Q4, year-ago quarter · EPS - · sales -1 EPS · 3 sales-
2027Q1ended 2027-03-31---0.080--18.50EPS - · sales -vs 2026Q1, year-ago quarter · EPS - · sales -1 EPS · 3 sales-
2027Q2ended 2027-06-30---0.080--20.22EPS - · sales -vs 2026Q2, year-ago quarter · EPS - · sales -1 EPS · 3 sales-
2027Q3ended 2027-09-30---0.080--23.13EPS - · sales -vs 2026Q3, year-ago quarter · EPS - · sales -1 EPS · 3 sales-
2027Q4ended 2027-12-31---0.080--25.86EPS - · sales -vs 2026Q4, year-ago quarter · EPS - · sales -1 EPS · 3 sales-
2028Q1ended 2028-03-31---0.600--42.40EPS - · sales -vs 2027Q1, year-ago quarter · EPS - · sales -1-

Annual earnings

2025FY EPS -2.110 missed -1.320, from -0.630 a year earlier. Sales 23.83 beat 8.00, from 4.14 a year earlier
EPS
0.0000-2.1102023FY EPS -0.490 against -0.48020232024FY EPS -0.630 against -0.57020242025FY EPS -2.110 against -1.3202025
Sales, USD millions
23.8302023FY sales 0.40 against 0.0020232024FY sales 4.14 against 4.1020242025FY sales 23.83 against 8.002025

Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.

earnings feed, not the snapshot. Not the statement ratio.

PeriodEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mP/E, earnings feed
2030FYestimate-0.530--721.123.62
2029FYestimate--0.500--550-
2028FYestimate--0.875--257.37-
2027FYestimate--0.320--87.71-
2026FYestimate--0.470--32.86-
2025FY-2.110-1.320-1.00023.838.00-
2024FY-0.630-0.570-0.6314.144.10-
2023FY-0.490-0.480-0.4930.400.00-

Quarterly results

2026Q2 revenue 5.12, from 1.20 a year earlier. Operating margin -667.97%, from -997.5% a year earlier
Revenue, USD millions
16.6602024Q3 revenue 1.0924Q32024Q4 revenue 1.1924Q42025Q1 revenue 1.1025Q12025Q2 revenue 1.2025Q22025Q3 revenue 4.8925Q32025Q4 revenue 16.6625Q42026Q1 revenue 4.1826Q12026Q2 revenue 5.1226Q2
Operating margin
0.00-997.52024Q3 operating margin -498.17%24Q32024Q4 operating margin -642.86%24Q42025Q1 operating margin -722.73%25Q12025Q2 operating margin -997.5%25Q22025Q3 operating margin -306.13%25Q32025Q4 operating margin -133.85%25Q42026Q1 operating margin -595.45%26Q12026Q2 operating margin -667.97%26Q2

From the quarterly statement. Not an estimate.

Estimate revisions

Latest snapshot of each period and type. 2026FY S 25.31 per share.
PeriodTypeScaleDateMeanvs prior date
2026FYSper share2026-11-0225.310.0%
2026FYEper share2026-08-16-0.470.0%
2026Q2Eper share2026-08-16-0.170.0%
2026Q2Sper share2026-08-164.470.0%
2026Q1Eper share2026-06-02-0.06-25.0%
2026Q1Sper share2026-06-024.43+20.4%
2026FYRper share2026-04-12-1.00+38.9%
2026Q1Rper share2026-03-28-0.170.0%
2026Q2Rper share2026-03-28-0.170.0%
2025FYEper share2026-02-07-1.250.0%
2025Q4Eper share2026-02-07-0.140.0%
2025FYSper share2026-02-078.000.0%
2025Q4Sper share2026-02-072.030.0%
2025Q4Rper share2026-01-12-0.17-5.6%
2025FYRper share2025-12-03-1.00-
2025Q3Eper share2025-11-24-0.15+30.4%
2025Q3Sper share2025-11-244.90+60.8%
2025Q2Eper share2025-08-19-1.03+836.4%
2025Q2Sper share2025-08-191.20-25.5%
2025Q1Eper share2025-05-22-0.12+20.0%
2025Q1Sper share2025-05-221.05-20.4%
2024Q4Sper share2025-01-131.200.0%
2024Q4Eper share2024-11-27-0.090.0%
2024FYEper share2024-11-14-0.57+40.7%
2024FYSper share2024-11-144.10-41.8%
2024Q3Sper share2024-10-301.10+3.5%
2024Q3Eper share2024-10-03-0.09-
2023FYEper share2023-12-04-0.48+220.0%
2024FYRper share2023-09-190.050.0%
2023FYRper share2023-07-06-0.15-
2023FYSper share2023-07-060.00-

Estimate history

Annual
Metric20212022202320242025TTMMRQ
EPS per share-0.076-0.138-0.493-0.631-2.109-1.3167-
Sales USD millions00042431-
Shares million shares34364972112-130
Quarterly
MetricQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
EPS per share-0.238-0.118-0.13-0.122-1.028-0.145-0.841-0.057-0.274
Sales USD millions1111151745
Shares million shares526872728493112126130

Income statement, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/2021
Total Revenue30.8523.85+476.1%4.14+862.8%0.430.000.00
Cost of Goods Sold Incl. D&A31.0022.36+780.3%2.54+775.9%0.29+314.3%0.07+250.0%0.02
Gross Profit-0.151.49-6.9%1.60+1042.9%0.14-0.07-0.02
Selling, General and Administrative Excl. Other96.2058.68+109.9%27.95+72.7%16.18+221.7%5.03+94.2%2.59
Research and Development22.0412.36+293.6%3.14+313.2%0.76-40.2%1.27+3075.0%0.04
Other Operating Expense0.000.000.000.000.000.00
Operating Income-96.35-57.19-26.35-16.04-5.10-2.61
Interest Expense3.910.57+119.2%0.26+116.7%0.12--
Unusual Expense46.68108.62+1449.5%7.01+3589.5%0.19-0.150.00
Net Income Before Taxes-136.79-159.56-32.31-16.30-4.95-2.61
Income Taxes0.130.28+154.5%0.11-0.010.000.00
Consolidated Net Income-136.92-159.84-32.42-16.29-4.95-2.61
Net Income From Continuing Operations-151.63-175.09-32.33-16.29-4.95-2.61
Net Income-132.05-175.09-35.11-16.29-4.95-2.61
EPS (Recurring) per share-0.81-1.19-0.54-0.49-0.14-0.08
EPS (Basic, Before Extraordinaries) per share-1.32-2.11-0.63-0.49-0.14-0.08
EPS (Diluted) per share-1.32-2.11-0.63-0.49-0.14-0.08
EBITDA-90.55-55.28-25.88-16.00-5.03-2.59
Non-Operating Income (Expense)10.156.83+421.4%1.31+2520.0%0.050.000.00
Other After Tax Adjustments0.000.000.000.000.000.00
Stock Option Compensation Expense14.7412.66+87.3%6.76-2.2%6.91+245.5%2.00+292.2%0.51
Price To Sales Ratio ratio24.7418.6260.85136.69--
Gross Margin %-0.496.2638.6032.09--
Operating Margin %-312.31-239.80-635.91-3,704.63--
Net Margin %-428.00-734.17-847.28-3,761.03--
Shares Outstanding million shares130.15111.68+55.0%72.07+47.3%48.92+36.2%35.91+4.5%34.36
Market Capitalization286.69286.69-11.4%323.40+514.4%52.64+13.3%46.460.0%46.46

Income statement, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/20242024Q39/30/2024
Total Revenue5.12+326.7%4.18+280.0%16.66+1300.0%4.89+348.6%1.20+17.6%1.10+31.0%1.19+176.7%1.09
Cost of Goods Sold Incl. D&A4.84+668.3%5.57+623.4%15.51+2528.8%5.07+541.8%0.63+5.0%0.77+16.7%0.59+103.4%0.79
Gross Profit0.28-50.9%-1.39-521.2%1.15+88.5%-0.19-165.5%0.57+35.7%0.33+83.3%0.61+335.7%0.29
Selling, General and Administrative Excl. Other34.47+174.9%23.50+183.8%23.45+184.2%14.78+157.9%12.54+59.1%8.28+38.2%8.25+98.3%5.73+45.1%
Research and Development6.82+675.0%5.26+243.8%6.85+382.4%3.10+201.0%0.88+87.2%1.53+595.5%1.42+1928.6%1.03+329.2%
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-34.20-24.89-22.30-14.97-11.97-7.95-7.65-5.43
Interest Expense1.77+2112.5%1.73+1822.2%0.26+188.9%0.15+66.7%0.08+14.3%0.09+800.0%0.09-25.0%0.09
Unusual Expense3.46-94.6%-0.56-159.6%43.88+1979.6%-0.10-104.3%63.90+4431.9%0.94-19.7%2.11+2244.4%2.31+725.0%
Net Income Before Taxes-34.09-26.74-63.15-12.82-75.06-8.53-9.07-7.36
Income Taxes-0.10-200.0%-0.030.18+20.0%0.070.10+900.0%-0.070.15-0.01
Consolidated Net Income-33.99-26.71-63.33-12.89-75.16-8.46-9.22-7.36
Net Income From Continuing Operations-33.59-26.46-78.71-12.87-75.06-8.45-9.18-7.27
Net Income-33.59-6.88-78.71-12.87-75.06-8.45-9.18-7.27
EPS (Recurring) per share-0.25-0.06-0.51-0.15-0.42-0.11-0.11-0.09
EPS (Basic, Before Extraordinaries) per share-0.27-0.06-0.84-0.15-1.03-0.12-0.13-0.12
EPS (Diluted) per share-0.27-0.06-0.84-0.15-1.03-0.12-0.13-0.12
EBITDA-32.99-21.83-21.37-14.36-11.44-7.80-7.60-5.26
Non-Operating Income (Expense)5.34+500.0%-0.68-251.1%3.30+323.1%2.19+366.0%0.89+1171.4%0.450.78+1460.0%0.47
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense3.59+2.6%3.49+134.2%4.12+130.2%3.54+117.2%3.50+75.9%1.49+10.4%1.79+459.4%1.63-21.3%
Price To Sales Ratio ratio24.7419.8621.00101.61117.2973.9777.2650.56
Gross Margin %5.43-33.286.88-3.7947.7429.6750.7427.03
Operating Margin %-667.48-595.41-133.88-306.10-998.76-721.89-640.58-499.55
Net Margin %-655.57-164.55-472.46-263.30-6,263.88-766.72-769.03-668.50
Shares Outstanding million shares130.15+55.1%125.90+74.7%111.68+55.0%93.38+36.5%83.91+61.0%72.07+48.3%72.07+47.3%68.41+78.4%
Market Capitalization286.69-53.6%552.99+65.2%592.99+83.4%884.20+376.9%617.32+289.7%334.82+66.2%323.40+514.4%185.39+563.5%

Balance sheet, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/2021
Cash & Short Term Investments333.31+438.6%61.89+682.4%7.91+231.0%2.39-19.0%2.95
Short Term Receivables51.71+6983.6%0.73-22.3%0.940.000.00
Inventories8.49+12028.6%0.070.000.000.00
Other Current Assets4.62+51.5%3.05+83.7%1.66+82.4%0.91+237.0%0.27
Total Current Assets398.14+505.6%65.74+525.5%10.51+218.5%3.30+2.5%3.22
Net Property, Plant & Equipment34.96+48.9%23.48+96.2%11.97+32.3%9.05+130.9%3.92
Total Investments and Advances47.310.000.000.000.00
Long-Term Note Receivable1.69----
Intangible Assets10.05+217.0%3.17-3.1%3.27-0.00
Deferred Tax Assets14.86+157.5%5.77+117.7%2.65--
Other Assets5.87+204.1%1.93+7.8%1.79+1178.6%0.140.00
Total Assets512.88+412.4%100.09+231.5%30.19+141.5%12.50+75.1%7.14
Short Term Debt Incl. Current Port. of LT Debt13.64+742.0%1.62+86.2%0.87+987.5%0.080.0%0.08
Accounts Payable5.75+463.7%1.020.000.00-100.0%0.06
Other Current Liabilities13.30+201.6%4.41-8.3%4.81+158.6%1.86+1062.5%0.16
Total Current Liabilities32.70+363.2%7.06+24.5%5.67+192.3%1.94+546.7%0.30
Long Term Debt202.32+460.1%36.12+2744.1%1.27+71.6%0.74-11.9%0.84
Provision for Risks Charges0.000.000.000.000.00
Deferred Tax Liabilities14.96+160.6%5.74+108.0%2.76--
Other Liabilities0.000.00-100.0%1.650.000.00
Total Liabilities249.98+411.0%48.92+330.6%11.36+323.9%2.68+135.1%1.14
Non-Equity Reserves0.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.00
Common Equity204.15+326.2%47.90+193.9%16.30+66.0%9.82+63.7%6.00
Total Shareholders Equity204.15+326.2%47.90+193.9%16.30+66.0%9.82+63.7%6.00
Accumulated Minority Interest58.75+1696.6%3.27+29.2%2.530.000.00
Total Equity262.90+413.8%51.17+171.7%18.83+91.8%9.82+63.7%6.00
Total Liabilities & Stockholders Equity512.88+412.4%100.09+231.5%30.19+141.5%12.50+75.1%7.14
Book Value Per Share per share1.83+177.3%0.66+100.0%0.33+22.2%0.27+58.8%0.17
Tangible Book Value Per Share per share1.74+180.6%0.62+129.6%0.270.0%0.27+58.8%0.17
Full-Time Employees people271+99.3%136+78.9%76+1800.0%4-
Price to Book Ratio ratio0.928.017.958.598.59
Return on Assets %-57.13-49.64-76.31-50.36-
Return on Equity %-138.93-100.74-124.73-62.54-
Return on Invested Capital %-43.08-38.48-92.70-46.83-38.13
Quick Ratio ratio11.929.311.851.7110.62
Current Ratio ratio12.189.311.851.7110.62

Cash flow, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/2021
Net Income-117.34-159.84-32.42-16.29-4.95-2.61
Depreciation5.491.91+306.4%0.47+1075.0%0.04-42.9%0.07+250.0%0.02
Other Funds (Non Cash)48.26123.83+587.2%18.02+86.3%9.67+408.9%1.90-15.6%2.25
Funds from Operations-63.83-34.15-14.07-6.57-2.97-0.34
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-3.98-3.63-2.62-325.9%1.16+3766.7%0.03-0.24
Cash from Operating Activities-67.80-37.78-16.70-5.41-2.94-0.58
Capital Expenditures-15.77-9.65-11.37-2.33-4.47-2.99
Net Assets From Acquisitions9.494.570.00-0.120.000.00
Sale of Fixed Assets and Businesses20.9220.80+2160.9%0.920.000.000.00
Purchase or Sale of Investments-77.36-75.740.000.000.000.00
Purchase of Investments-125.23-75.740.000.000.000.00
Sale Or Maturity of Investments47.870.000.000.000.000.00
Other Uses-50.70-30.000.000.000.000.00
Other Sources0.300.030.000.000.000.00
Cash from Investing Activities-113.12-90.00-10.45-2.45-4.47-2.99
Cash Dividends Paid0.000.000.000.000.000.00
Change in Capital Stock255.55307.09+455.5%55.28+292.3%14.09+111.9%6.65+3.1%6.45
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock255.55307.09+455.5%55.28+292.3%14.09+111.9%6.65+3.1%6.45
Proceedsfrom Stock Options255.41302.17+511.2%49.44+250.9%14.09+111.9%6.65+3.1%6.45
Issuance or Reduction of Debt, Net41.1644.11+71.5%25.72-0.71-0.01-120.0%0.05
Change in Long Term Debt38.5941.54+61.5%25.720.000.000.00
Issuance of Long Term Debt57.6857.68+118.2%26.440.000.000.00
Reduction of Long Term Debt-19.10-16.14-0.710.000.000.00
Net Financing Active Other Cash Flow43.98-0.40-165.6%0.610.000.000.00
Other Financing Activities Uses-1.90-0.40-0.100.000.000.00
Cash from Financing Activities340.69350.80+329.8%81.61+509.5%13.39+101.7%6.64+2.2%6.50
Exchange Rate Effect-2.000.65-0.48-0.00-100.0%0.21+950.0%0.02
Net Change in Cash157.77223.67+314.4%53.98+877.9%5.52-0.56-119.0%2.95
Free Cash Flow-83.58-47.43-28.07-7.74-7.41-3.57
Preferred Dividends (Cash Flow)-0.00-0.000.000.00
Deferred Taxes & Investment Tax Credit--0.04-0.14-800.0%0.020.000.00

Balance sheet, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/20242024Q39/30/2024
Cash & Short Term Investments259.02+282.7%293.28+424.0%333.31+438.6%113.94+120.9%67.68+139.5%55.97+134.3%61.89+682.4%51.57+2152.0%
Short Term Receivables4.59-85.2%4.59+565.2%51.71+6983.6%50.13+8851.8%31.03+5867.3%0.69+97.1%0.73-22.3%0.56
Inventories1.53+45.7%1.37+302.9%8.49+12028.6%1.37+1612.5%1.050.340.070.08
Other Current Assets6.37+248.1%6.54+222.2%4.62+51.5%8.42+117.6%1.83-43.7%2.03+5.2%3.05+83.7%3.87+779.5%
Total Current Assets271.50+167.3%305.78+418.0%398.14+505.6%173.87+210.0%101.59+217.2%59.03+125.5%65.74+525.5%56.09+1954.6%
Net Property, Plant & Equipment240.69+741.0%224.88+751.5%34.96+48.9%31.90+31.0%28.62+49.1%26.41+66.7%23.48+96.2%24.35+171.5%
Total Investments and Advances45.9742.0747.316.320.000.000.000.00
Intangible Assets7.10+111.3%7.07+116.9%10.05+217.0%8.04+132.4%3.36+2.1%3.26+2.8%3.17-3.1%3.46
Deferred Tax Assets-0.07-36.4%14.86+157.5%0.070.030.115.77+117.7%-
Other Assets2.74+41.2%3.89+88.8%5.87+204.1%4.25+1747.8%1.94+676.0%2.06+930.0%1.93+7.8%0.23+35.3%
Total Assets572.05+320.9%587.67+546.7%512.88+412.4%225.89+168.5%135.91+148.2%90.87+100.2%100.09+231.5%84.13+608.8%
Short Term Debt Incl. Current Port. of LT Debt55.61+5517.2%54.22+3538.9%13.64+742.0%13.04+887.9%0.99+43.5%1.49+93.5%1.62+86.2%1.32+1550.0%
Accounts Payable5.70+119.2%6.87+235.1%5.75+463.7%3.42+90.0%2.60+7.0%2.05-7.7%1.021.80
Other Current Liabilities8.97+171.0%9.28+99.6%13.30+201.6%11.86+175.2%3.31-32.2%4.65+7.1%4.41-8.3%4.31+71.0%
Total Current Liabilities70.28+918.6%70.37+760.3%32.70+363.2%28.32+281.2%6.90-13.9%8.18+11.6%7.06+24.5%7.43+185.8%
Long Term Debt213.93+112.4%207.62+461.7%202.32+460.1%100.62+190.8%100.70+228.4%36.96+58.5%36.12+2744.1%34.60+5392.1%
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Deferred Tax Liabilities8.015.9814.96+160.6%0.31+287.5%--5.74+108.0%0.08
Other Liabilities5.034.690.000.030.00-100.0%0.00-100.0%0.00-100.0%0.00
Total Liabilities297.26+176.3%288.65+539.3%249.98+411.0%129.29+207.0%107.60+166.3%45.15+39.5%48.92+330.6%42.11+1203.7%
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity264.69+949.1%289.00+579.8%204.15+326.2%74.07+91.4%25.23+129.2%42.51+304.1%47.90+193.9%38.70+347.9%
Total Shareholders Equity264.69+949.1%289.00+579.8%204.15+326.2%74.07+91.4%25.23+129.2%42.51+304.1%47.90+193.9%38.70+347.9%
Accumulated Minority Interest10.10+227.9%10.02+212.1%58.75+1696.6%22.54+578.9%3.08-8.1%3.21+27.9%3.27+29.2%3.32
Total Equity274.79+870.6%299.02+553.9%262.90+413.8%96.60+129.9%28.31+97.1%45.73+251.0%51.17+171.7%42.01+386.2%
Total Liabilities & Stockholders Equity572.05+320.9%587.67+546.7%512.88+412.4%225.89+168.5%135.91+148.2%90.87+100.2%100.09+231.5%84.13+608.8%
Book Value Per Share per share2.03+576.7%2.30+289.8%1.83+177.3%0.79+38.6%0.30+42.9%0.59+168.2%0.66+100.0%0.57+147.8%
Tangible Book Value Per Share per share1.98+661.5%2.24+314.8%1.74+180.6%0.71+36.5%0.26+73.3%0.54+260.0%0.62+129.6%0.52+126.1%
Full-Time Employees people--271+99.3%---136+78.9%-
Price to Book Ratio ratio0.925.576.7431.9912.487.068.0113.16
Return on Assets %-42.84-56.92-57.13-68.10-104.85-49.66-49.64-56.91
Return on Equity %-104.60-116.50-138.93-187.23-551.61-127.59-100.74-115.41
Return on Invested Capital %-7.02-1.38-19.36-7.37-59.61-10.63-10.93-9.92
Quick Ratio ratio3.844.3311.926.0914.567.179.317.54
Current Ratio ratio3.864.3512.186.1414.727.219.317.55

Cash flow, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/20242024Q39/30/2024
Net Income-33.99-7.12-63.33-12.89-75.16-8.46-9.22-7.36
Depreciation1.20+126.4%3.06+1940.0%0.94+1780.0%0.30+66.7%0.53+253.3%0.15+50.0%0.05+25.0%0.18
Other Funds (Non Cash)3.63-94.7%-7.47-328.4%48.39+852.6%3.72-20.3%68.45+1384.8%3.27-10.9%5.08+125.8%4.67+81.7%
Funds from Operations-29.28-11.61-14.08-8.85-6.10-5.12-4.21-2.50
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital5.95-6.15-415.4%-3.77-937.8%-0.01-1.801.95+622.2%0.45-2.34-327.2%
Cash from Operating Activities-23.33-17.76-17.85-8.86-7.90-3.17-3.76-4.84
Capital Expenditures-4.09-6.14-2.40-3.15-1.75-2.36-3.02-4.48
Net Assets From Acquisitions0.004.92-2.076.640.000.000.000.00
Sale of Fixed Assets and Businesses0.120.0020.80+69233.3%0.00-100.0%0.00-100.0%0.000.030.08
Purchase or Sale of Investments8.38-10.00-70.74-5.000.000.000.000.00
Purchase of Investments-39.49-10.00-70.74-5.000.000.000.000.00
Sale Or Maturity of Investments47.870.000.000.000.000.000.000.00
Other Uses35.42-86.120.000.00-30.000.000.000.00
Other Sources0.120.160.030.000.000.000.000.00
Cash from Investing Activities39.95-97.18-54.38-1.50-31.75-2.36-2.99-4.40
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00--
Change in Capital Stock0.41-99.2%-0.27199.11+1041.7%56.31+74.1%51.68+837.9%0.0017.44+81.7%32.35
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.41-99.2%-0.27199.11+1041.7%56.31+74.1%51.68+837.9%0.0017.44+81.7%32.35
Proceedsfrom Stock Options0.27-99.4%-0.27199.10+1061.6%56.31+110.0%46.76+748.6%0.0017.14+78.5%26.81
Issuance or Reduction of Debt, Net-1.96-1.8144.80+17130.8%0.13+550.0%-0.60-111.7%-0.22-101.1%0.260.02
Change in Long Term Debt-1.96-1.8142.23+16142.3%0.13-0.60-111.3%-0.22-101.1%0.26-0.41
Issuance of Long Term Debt0.000.050.0%54.87+10874.0%2.760.00-100.0%0.05-99.8%0.500.00
Reduction of Long Term Debt-1.96-1.87-12.65-2.63-0.60-0.26-0.24-0.41
Net Financing Active Other Cash Flow-0.9445.25-0.590.27-0.07-110.1%-0.01-0.04-0.03
Other Financing Activities Uses-0.94-0.640.00-0.32-0.04-0.04-0.04-0.03
Cash from Financing Activities-2.50-104.9%43.17243.32+1277.8%56.70+75.3%51.01+349.8%-0.23-101.1%17.66+98.7%32.34
Exchange Rate Effect-0.42-216.7%-2.040.54-0.08-138.1%0.36-0.17-0.59-1280.0%0.21
Net Change in Cash13.71+17.1%-73.82171.62+1563.0%46.26+98.5%11.71+168.0%-5.92-137.0%10.32+83.6%23.31
Free Cash Flow-27.42-23.90-20.25-12.01-9.65-5.53-6.78-9.32

Revenue breakdown

USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.

Product
Name20242025vs 20242025 share
Collaboration0.20---
Construction-18.18-76.2%
Product3.945.67+43.9%23.8%
Total4.1423.85+475.5%100.0%
Region
Name20242025vs 20242025 share
Hong Kong-18.18-76.2%
South Africa4.144.82+16.4%20.2%
United States-0.85-3.6%
Total4.1423.85+475.5%100.0%

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3022.93%31.4M136.8M4.08M
2026-10-1521.23%29.0M136.8M4.17M
2026-09-3019.33%26.5M136.9M3.93M
2026-09-1519.05%26.1M136.9M3.91M
2026-08-3119.17%25.5M132.9M4.23M
2026-08-1420.15%26.8M132.9M4.81M
2026-07-3124.41%26.6M109.2M4.99M
2026-07-1522.21%24.2M109.2M4.90M
2026-06-3021.77%23.8M109.2M5.00M
2026-06-1521.21%23.1M108.9M5.07M
2026-05-2920.74%22.6M108.9M5.03M
2026-05-1520.44%23.1M113.0M4.46M
2026-04-3022.10%24.9M112.9M4.55M
2026-04-1522.44%25.3M112.9M5.08M
2026-03-3122.79%25.5M111.8M5.44M
2026-03-1320.07%22.4M111.8M5.40M
2026-02-2721.76%24.3M111.8M5.39M
2026-02-1320.27%22.7M111.8M6.05M
2026-01-3018.67%20.6M110.3M6.37M
2026-01-1519.24%21.2M110.3M6.81M

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call0.501.251.451.42-6021.000.961-0.1020.000
call1.000.751.000.80-48.002.000.870-0.2330.000
call1.500.250.600.35-8.0020.000.752-0.1910.000
call2.000.000.100.10-4820.000.404-0.0860.000
call2.500.000.200.03-1421.000.192-0.0880.000
call3.000.000.050.05-12.000.000.158-0.0470.000
call3.500.000.200.10-1580.000.136-0.1150.000
call4.000.000.200.05-32.000.000.124-0.1230.000
call4.500.000.050.00-0.000.000.116-0.0600.000
call5.000.000.050.01-1.000.000.110-0.1140.000
call5.500.000.450.00-0.000.000.106-0.1400.000
put0.500.000.050.00-0.000.00-0.039-0.1010.000
put1.000.000.200.00-0.000.00-0.130-0.2330.000
put1.500.000.200.02-1.000.00-0.248-0.1910.000
put2.000.100.200.15-31717.00-0.596-0.0850.000
put2.500.400.900.65-238199-0.808-0.0880.000
put3.000.901.401.02-8.000.00-0.845-0.1040.000
put3.501.401.901.46-1.000.00-0.864-0.1150.000
put4.001.902.401.95-0.000.00-0.876-0.1230.000
put4.502.402.902.46-2.000.00-0.883-0.1290.000
put5.002.903.402.96-0.000.00-0.889-0.1350.000
put5.503.403.903.47-1.000.00-0.894-0.1390.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-06425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-11-05425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-10-26425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-10-268-KCurrent report2026-10-26SEC
2026-10-214Statement of changes in beneficial ownership of securities2026-10-16SEC
2026-10-16144Filing for proposed sale of securities under Rule 144.SEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-14SEC
2026-10-158-KCurrent report2026-10-15SEC
2026-10-14144Filing for proposed sale of securities under Rule 144.SEC
2026-10-083Initial statement of beneficial ownership of securities2026-10-01SEC
2026-10-08SCHEDULE 13DSEC
2026-10-028-KCurrent report2026-10-02SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-09-304Statement of changes in beneficial ownership of securities2026-09-28SEC
2026-09-25144Filing for proposed sale of securities under Rule 144.SEC
2026-09-104Statement of changes in beneficial ownership of securities2026-09-08SEC
2026-09-09425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-09-09425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-09-088-KCurrent report2026-09-08SEC
2026-09-044Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-044Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-044Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-02144Filing for proposed sale of securities under Rule 144.SEC
2026-09-02144Filing for proposed sale of securities under Rule 144.SEC
2026-09-02144Filing for proposed sale of securities under Rule 144.SEC
2026-08-21425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-08-208-KCurrent report2026-08-14SEC
2026-08-20425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-08-208-KCurrent report2026-08-20SEC
2026-08-188-KCurrent report2026-08-18SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100095.37K2
2026-0961.80K21.23M6
2026-080000
2026-0700145.22K1
2026-06003.48M8
2026-050000
2026-0400304.38K3
2026-0300158.67K2
2026-020000
2026-010000
2025-12001.45M3
2025-11001.78M4

Institutional holders

Manager% owned
BlackRock, Inc.7.32%
Encompass Capital Advisors LLC5.21%
UBS Group AG4.12%
VANGUARD CAPITAL MANAGEMENT LLC3.96%
Rovida Investment Management Ltd3.26%
GEODE CAPITAL MANAGEMENT, LLC2.40%
Alyeska Investment Group, L.P.2.26%
STATE STREET CORP1.89%
AWM Investment Company, Inc.1.26%
BNP Paribas Asset Management Holding S.A.1.25%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.85%
iShares Russell 2000 ETF2.42%
Range Nuclear Renaissance Index ETF1.41%
Fidelity Small Cap Index Fund1.01%
VANGUARD EXTENDED MARKET INDEX FUND1.00%
iShares Russell 2000 Growth ETF0.72%
American Beacon GLG Natural Resources ETF0.67%
Pacer Data & Infrastructure Real Estate ETF0.59%
VANGUARD RUSSELL 2000 INDEX FUND0.44%
Fidelity Extended Market Index Fund0.37%

OakChart. ASPI. Cached 15 minutes. Terms